Home

Evolent Health, Inc Class A Common Stock (EVH)

8.7800
+0.0100 (0.11%)

Evolent Health Inc. is a leading healthcare technology and services company that partners with healthcare organizations to improve their clinical and financial performance

By providing innovative solutions, including data-driven insights, care management tools, and population health strategies, Evolent Health helps organizations transition to value-based care models. Their integrated approach aims to enhance patient outcomes, optimize resource utilization, and empower healthcare providers through streamlined operations and advanced analytics. The company focuses on transforming the healthcare landscape by enabling more effective delivery of healthcare services and fostering better health experiences for patients.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close8.770
Open8.600
Bid8.770
Ask8.790
Day's Range8.471 - 8.840
52 Week Range8.400 - 35.00
Volume952,808
Market Cap766.21M
PE Ratio (TTM)-10.71
EPS (TTM)-0.8
Dividend & YieldN/A (N/A)
1 Month Average Volume2,784,281

News & Press Releases

Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect
Telehealth company Hims & Hers Health (NYSEHIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know.
Via StockStory · February 23, 2025
Evolent Health (EVH) Q4 2024 Earnings Call Transcriptfool.com
EVH earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 21, 2025
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets
Healthcare solutions company Evolent Health (NYSEEVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue guidance of $455 million underwhelmed, coming in 22.7% below analysts’ estimates. Its non-GAAP loss of $0.02 per share was significantly below analysts’ consensus estimates.
Via StockStory · February 20, 2025
Earnings Scheduled For February 20, 2025benzinga.com
Via Benzinga · February 20, 2025
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For
Healthcare solutions company Evolent Health (NYSEEVH) will be reporting results tomorrow after market close. Here’s what to expect.
Via StockStory · February 19, 2025
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)benzinga.com
Via Benzinga · February 12, 2025
What Analysts Are Saying About Evolent Health Stockbenzinga.com
Via Benzinga · January 14, 2025
Cracking The Code: Understanding Analyst Reviews For Evolent Healthbenzinga.com
Via Benzinga · November 8, 2024
Expert Outlook: Evolent Health Through The Eyes Of 7 Analystsbenzinga.com
Via Benzinga · October 8, 2024
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates
Health insurance provider Elevance Health (NYSEEVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus estimates.
Via StockStory · January 31, 2025
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Miningmarkets/com
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.
Via Benzinga · November 22, 2024
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foulbenzinga.com
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.
Via Benzinga · November 17, 2024
Evolent Health (EVH) Q3 2024 Earnings Call Transcriptfool.com
EVH earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 8, 2024
S&P 500 Tops 6,000; Sezzle Shares Spike Higherbenzinga.com
Via Benzinga · November 8, 2024
Dow Tops 44,000; US Consumer Sentiment Increases In Novemberbenzinga.com
Via Benzinga · November 8, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · November 8, 2024
US Stocks Mixed; Fluor Earnings Miss Viewsbenzinga.com
Via Benzinga · November 8, 2024
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 8, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 8, 2024
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 8, 2024
Humana and Evolent Expand Partnership to Enhance Oncology Care
Humana Inc. (NYSEHUM) and Evolent Health, Inc. NYSE: EVHNYSEEVH)
By Evolent Health, Inc. · Via Business Wire · November 7, 2024
Why Is Elevance Health Stock Trading Lower On Thursday?benzinga.com
Evolent Health stock reacted negatively amid Elevance Health's mixed results and Medicaid utilization pressures.
Via Benzinga · October 17, 2024
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?benzinga.com
The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.
Via Benzinga · September 8, 2024
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?benzinga.com
Via Benzinga · August 25, 2024
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firmsbenzinga.com
Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.
Via Benzinga · August 23, 2024